Defective serum opsonization activity in children aged 6-48 months having acute purulent otitis media

Turkish Journal of Pediatrics

Volumn 39, Issue 4, 1997, Pages 453-457

  Tezcan, Ilhan ^a   Yilmaz, Yeşim ^c   Öner, Filiz ^a   Yel, Leman ^b   Sanal, Özden ^a   Ersoy, Fügen ^a   Önerci, Metin ^a   Izzet Berkel, A ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Department of Immunology   (United States)

^c St Jude Children's Hospital USA ^*

Author keywords

Acute otitis media; Common opsonic defect; Mannan binding lectin

Indexed keywords

MANNAN; OPSONIN;

ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; HUMAN; IMMUNOLOGY; INFANT; MALE; NONPARAMETRIC TEST; PHAGOCYTOSIS; PHYSIOLOGY; PRESCHOOL CHILD; RISK FACTOR; SACCHAROMYCES CEREVISIAE; SUPPURATIVE OTITIS MEDIA;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MANNANS; OPSONIN PROTEINS; OTITIS MEDIA, SUPPURATIVE; PHAGOCYTOSIS; RISK FACTORS; SACCHAROMYCES CEREVISIAE; STATISTICS, NONPARAMETRIC;

EID: 0031242224     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study J Infect Dis 1989; 160: 83-94.
2. Hoekelman RA. Infectious illness during the first year of life. Pediatrics 1977; 59: 119-124.
3. Klein JO, Teele DW, Pelton SI. New concepts in otitis media: results of investigations of the Greater Boston Otitis Media Study Group. Adv Pediatr 1992; 39: 127-156.
4. Turner MW. Mannose binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996; 17: 532-540.
5. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW. Association of low levels of mannan binding protein with a common defect of opsonisation. Lancet 1989, 2: 1236-1239.
6. Sumiya M, Super M, Tabona P, et al. Molecular basis of opsonic defect in immunodeficient children. Lancet 1991; 337: 1569-1570.
7. Levinsky RJ, Harvey BAM, Paleja S. A rapid objective method for measuring the yeast opsonisation activity of serum. J Immunol Methods 1978; 24: 251-256.
8. Miller ME, Seals J, Kaye R, Levitsky LC. A familial plasma-associated defect of phagocytosis. Lancet 1968; ii: 60-63.
9. Soothill JF, Harvey BAM. Defective opsonisation: a common immunity deficiency. Arch Dis Child 1976; 51: 91-99.
10. Richardson VF, Larcher VF, Price JF. A common congenital immunodeficiency predisposing to infection and atopy in infancy. Arch Dis Child 1983; 58: 799-802.
11. Kerr MA, Falconer JS, Bashey A, Beck JS. The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin. Clin Exp Immunol 1983; 54: 793-800.
12. Turner MW, Super M, Singh S, Levinsky RJ. Molecular basis of a common opsonic defect. Clin Exp Allergy 1991; 21 (Suppl 1): 182-188.
13. Garred P, Madsen HO, Hofmann B, Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet 1995; 346: 941-943.
14. Garred P, Brygge K, Sprensen CH, Madsen HO, Thiel S, Svejgaard A. Mannan-binding protein-levels in plasma and upper-airways secretions and frequency of genotypes in children with recurrence of otitis media. Clin Exp Immunol 1993; 94: 99-104.
15. Summerfield JA, Sumiya M, Levin M, Turner MW. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. Br Med J 1997; 314: 1229-1232.